SENSORION news, videos and press releases
For more news please use our advanced search feature.
SENSORION - More news...
SENSORION - More news...
- Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
- Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
- Sensorion Announces Presentation by Pr. Natalie Loundon at the 2025 American Society of Pediatric Otolaryngology Annual Meeting
- Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 12, 2025
- Sensorion to Host a Symposium during ISIET’s International Conference on Inner Ear Therapies on April 26, 2025
- Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director
- Sensorion Announces Webconference, in French, for its Retail Shareholders on April 7, 2025
- Sensorion Announces its Participation at the Van Lanschot Kempen Conference Life Sciences
- Sensorion Reports Full-Year 2024 Results, Provides Corporate Update and Announces Availability of Full-Year Report
- Sensorion Announces the End of Patient Inclusion in NOTOXIS Phase 2a Clinical Trial of SENS-401 for the Prevention of Cisplatin-Induced Ototoxicity
- Sensorion Receives Positive Recommendation from Data Monitoring Committee of SENS-501’s Audiogene Phase 1/2 Clinical Trial
- Sensorion Announces Its Participation in Several Investor Conferences to be Held in March
- Sensorion Announces Its Participation In Several Congresses To Be Held In March
- Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting
- Sensorion Announces Completion of Enrollment of The First Cohort of The Audiogene Phase 1/2 Gene Therapy Clinical Trial
- Sensorion Reports Data in the Audiogene Phase 1/2 Gene Therapy Clinical Trial
- Sensorion to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Sensorion Completes a Private Placement of €35 Million Subscribed by Leading US and European Biotech Investors
- Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe
- Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK
- Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study
- Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study
- Sensorion to Host Key Opinion Leader Webinar on July 5, 2023; Confirms Upcoming Key Milestones
- Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions
- Sensorion Will Present Two Posters At The American Society Of Cell And Gene Therapy (ASGCT) 26th Annual Meeting
- Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023
- Sensorion to Host a Symposium during ISIET’s International Symposium on Inner Ear Therapeutics on April 30, 2023
- Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference
- Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program
- Sensorion Appoints Khalil Barrage as Interim Chairman of the Board
